Table 2. Current pulmonary hypertension classification (6).
Group | Subgroup |
---|---|
Group 1: pulmonary arterial hypertension | 1.1 Idiopathic PAH |
1.2 Heritable PAH | |
1.3 Drug- and toxin-induced | |
1.4 Associated with connective tissue disease, human immunodeficiency virus infection, portal hypertension, congenital heart disease and schistosomiasis | |
Group 2: PH secondary to left heart disease | 2.1 PH due to heart failure with preserved left ventricular ejection fraction |
2.2 PH due to heart failure with reduced left ventricular ejection fraction | |
2.3 Valvular heart disease | |
2.4 Congenital/acquired cardiovascular conditions leading to post-capillary PH | |
Group 3: PH secondary to lung diseases +/- hypoxia | 3.1 Obstructive lung disease |
3.2 Restrictive lung disease | |
3.3 Other lung disease with mixed restrictive/obstructive pattern | |
3.4 Hypoxia without lung disease | |
3.5 Developmental lung disorders | |
Group 4: Chronic thromboembolic PH | |
Group 5: PH with unclear multifactorial mechanism | 5.1 Haematological disorders |
5.2 Systemic and metabolic disorders | |
5.3 Others | |
5.4 Complex congenital heart disease |
PAH, pulmonary arterial hypertension; PH, pulmonary hypertension.